IMPACT OF ROSUVASTATIN ON PROGRESSION OF ATHEROSCLEROSIS IN PEOPLE WITH HIV AT MODERATE CARDIOVASCULAR RISK: A MULTICENTRE, RANDOMISED, DOUBLE BLIND, PLACEBO-CONTROLLED TRIAL

被引：0
|
作者：
Trevillyan, J. M. [1 ,2 ]
Dart, A. [3 ]
Cavassini, M. [4 ,5 ]
Fehr, J. [4 ,5 ]
Staehelin, C. [6 ]
Dewar, L. [3 ]
Calmy, A. [7 ]
Hoy, J. F. [1 ,2 ]
机构：
[1] Alfred Hlth, Dept Infect Dis, Melbourne, Vic, Australia
[2] Monash Univ, Melbourne, Vic, Australia
[3] Alfred Hlth, Dept Cardiol, Melbourne, Vic, Australia
[4] Univ Zurich, Biostat & Prevent Inst, Dept Publ Hlth Epidemiol, Zurich, Switzerland
[5] Univ Zurich, Univ Zurich Hosp, Div Infect Dis & Hosp Epidemiol, Zurich, Switzerland
[6] Inselspital Bern, Univ Klin Infektiol, Bern, Switzerland
[7] Univ Hosp Geneva, Geneva, Switzerland
来源：
SEXUAL HEALTH | 2020年 / 17卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
19
引用
收藏
页码：XXI / XXI
页数：1
相关论文
共 50 条
  • [21] Azithromycin for prevention of exacerbations in severe asthma (AZISAST): a multicentre randomised double-blind placebo-controlled trial
    Brusselle, Guy G.
    VanderStichele, Christine
    Jordens, Paul
    Deman, Rene
    Slabbynck, Hans
    Ringoet, Veerle
    Verleden, Geert
    Demedts, Ingel K.
    Verhamme, Katia
    Delporte, Anja
    Demeyere, Benedicte
    Claeys, Geert
    Boelens, Jerina
    Padalko, Elizaveta
    Verschakelen, Johny
    Van Maele, Georges
    Deschepper, Ellen
    Joos, Guy F. P.
    THORAX, 2013, 68 (04) : 322 - 329
  • [22] A multicentre, randomised, double-blind, placebo-controlled trial of aminophylline for bronchiolitis in infants admitted to intensive care
    Turner, Alastair
    Shann, Frank
    Delzoppo, Carmel
    Henning, Robert
    Slater, Anthony
    Beca, John
    Erickson, Simon
    Butt, Warwick
    CRITICAL CARE AND RESUSCITATION, 2014, 16 (03) : 220 - 224
  • [23] Safety and efficacy of metformin in systemic lupus erythematosus: a multicentre, randomised, double-blind, placebo-controlled trial
    Sun, Fangfang
    Wang, Hui Jing
    Liu, Zhe
    Geng, Shikai
    Wang, Haiting
    Wang, Xiaodong
    Li, Ting
    Morel, Laurence
    Wan, Weiguo
    Lu, Liangjing
    Teng, Xiangyu
    Ye, Shuang
    LANCET RHEUMATOLOGY, 2020, 2 (04): : E210 - E216
  • [24] Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial
    Thwaites, Guy E.
    Scarborough, Matthew
    Szubert, Alexander
    Nsutebu, Emmanuel
    Tilley, Robert
    Greig, Julia
    Wyllie, Sarah A.
    Wilson, Peter
    Auckland, Cressida
    Cairns, Janet
    Ward, Denise
    Lal, Pankaj
    Guleri, Achyut
    Jenkins, Neil
    Sutton, Julian
    Wiselka, Martin
    Armando, Gonzalez-Ruiz
    Graham, Clive
    Chadwick, Paul R.
    Barlow, Gavin
    Gordon, N. Claire
    Young, Bernadette
    Meisner, Sarah
    McWhinney, Paul
    Price, David A.
    Harvey, David
    Nayar, Deepa
    Jeyaratnam, Dakshika
    Planche, Tim
    Minton, Jane
    Hudson, Fleur
    Hopkins, Susan
    Williams, John
    Torok, M. Estee
    Llewelyn, Martin J.
    Edgeworth, Jonathan D.
    Walker, A. Sarah
    LANCET, 2018, 391 (10121): : 668 - 678
  • [25] Etanercept in patients with inflammatory hand osteoarthritis (EHOA): a multicentre, randomised, double-blind, placebo-controlled trial
    Kloppenburg, Margreet
    Ramonda, Roberta
    Bobacz, Klaus
    Kwok, Wing-Yee
    Elewaut, Dirk
    Huizinga, Tom W. J.
    Kroon, Feline P. B.
    Punzi, Leonardo
    Smolen, Josef S.
    Cruyssen, Bert Vander
    Wolterbeek, Ron
    Verbruggen, Gust
    Wittoek, Ruth
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 (12) : 1757 - 1764
  • [26] Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial
    Tavazzi, Luigi
    Maggioni, Aldo P.
    Marchioli, Roberto
    Barlera, Simona
    Franzosi, Maria Grazia
    Latini, Roberto
    Lucci, Donata
    Nicolosi, Gian Luigi
    Porcu, Maurizio
    Tognoni, Gianni
    LANCET, 2008, 372 (9645): : 1231 - 1239
  • [27] A MULTICENTRE RANDOMISED DOUBLE-BLIND PLACEBO-CONTROLLED TRIAL OF ZOLEDRONIC ACID FOR KNEE OSTEOARTHRITIS - THE ZAP2 TRIAL
    Aitken, D.
    Cai, G.
    Laslett, L. L.
    Hill, C.
    March, L.
    Cicuttini, F.
    Wluka, A. E.
    Wang, Y.
    Antony, B.
    Blizzard, L.
    Winzenberg, T.
    Martel-Pelletier, J.
    Pelletier, J. -P.
    Jones, G.
    OSTEOARTHRITIS AND CARTILAGE, 2020, 28 : S79 - S80
  • [28] A randomised, multicentre, double-blind, placebo-controlled trial of etanercept in adults with refractory heel enthesitis in spondyloarthritis: the HEEL trial
    Dougados, Maxime
    Combe, Bernard
    Braun, Juergen
    Landewe, Robert
    Sibilia, Jean
    Cantagrel, Alain
    Feydy, Antoine
    van der Heijde, Desiree
    Leblanc, Veronique
    Logeart, Isabelle
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (08) : 1430 - 1435
  • [29] Estrogen in the prevention of atherosclerosis - A randomized, double-blind, placebo-controlled trial
    Hodis, HN
    Mack, WJ
    Lobo, RA
    Shoupe, D
    Sevanian, A
    Mahrer, PR
    Selzer, RH
    Liu, CR
    Liu, CH
    Azen, SP
    ANNALS OF INTERNAL MEDICINE, 2001, 135 (11) : 939 - 953
  • [30] Bimekizumab efficacy and safety in moderate to severe plaque psoriasis (BE READY): a multicentre, double-blind, placebo-controlled, randomised withdrawal phase 3 trial
    Gordon, Kenneth B.
    Foley, Peter
    Krueger, James G.
    Pinter, Andreas
    Reich, Kristian
    Vender, Ronald
    Vanvoorden, Veerle
    Madden, Cynthia
    White, Katy
    Cioffi, Christopher
    Blauvelt, Andrew
    LANCET, 2021, 397 (10273): : 475 - 486
12345